# Immuron Ltd

Immuron Ltd is an other.

## Overview

- **Organization type:** other
- **Assets under management:** Undisclosed
- **Website:** https://immuron.com
- **LinkedIn:** https://www.linkedin.com/company/immuronltd

## Regulatory record

- **Reports private funds:** No

## About

Immuron Ltd is a publicly traded Australian biopharmaceutical firm (ASX: IMC) that develops oral immunotherapies targeting enteric diseases such as traveler's diarrhea and Clostridium difficile infection. The company's lead product, Travelan, is an over-the-counter oral antibody derived from bovine colostrum.

## Questions

### What does Immuron Ltd do?

Immuron develops oral immunotherapies for gastrointestinal infections, including Travelan for traveler's diarrhea and a therapeutic for C. difficile infection. Its products are based on hyperimmune bovine colostrum technology.

### Who are Immuron Ltd's key executives?

As of public filings, key personnel include CEO and Managing Director Steven Lydeamore. No named investment principals or family-office-related individuals are disclosed.

## Related profiles

- [Alpha Compute Corp](https://altss.com/profile/alpha-compute-corp)
- [Acurx Pharmaceuticals, Inc.](https://altss.com/profile/acurx-pharmaceuticals-inc)

---

Last updated: 2026-08-11T02:43:31.692Z

Canonical page: https://altss.com/profile/immuron-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology